Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C

作者: Chaohua Peng , Gaochun Zhu , Xiangqian Liu , He Li

DOI: 10.1007/S12264-018-0230-X

关键词:

摘要: Huntington's disease (HD) is a neurodegenerative caused by polyglutamine expansion in the huntingtin (Htt) protein. Mutant Htt causes synaptic transmission dysfunctions interfering expression of proteins, leading to early HD symptoms. Synaptic vesicle proteins 2 (SV2s), family including 3 members, SV2A, SV2B, and SV2C, plays important roles physiology. Here, we investigated whether SV2s affected mutant brains transgenic (TG) mice Neuro2a mouse neuroblastoma cells (N2a cells) expressing Htt. Western blot analysis showed that protein levels SV2A SV2B were not significantly changed TG with 82 glutamine repeats. However, brain there was dramatic decrease level which has restricted distribution pattern regions particularly vulnerable HD. Immunostaining revealed immunoreactivity SV2C progressively weakened basal ganglia hippocampus mice. RT-PCR demonstrated mRNA declined without detectable changes indicating selectively inhibits transcriptional SV2C. Furthermore, found only inhibited N2a containing 120 These findings suggest dysfunction results from Htt-mediated inhibition expression. data also imply decreased contribute region-selective pathology

参考文章(112)
Lisa A. Gunaydin, Anatol C. Kreitzer, Cortico–Basal Ganglia Circuit Function in Psychiatric Disease Annual Review of Physiology. ,vol. 78, pp. 327- 350 ,(2016) , 10.1146/ANNUREV-PHYSIOL-021115-105355
Caodu Buren, Matthew P. Parsons, Amy Smith-Dijak, Lynn A. Raymond, Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease Neurobiology of Disease. ,vol. 87, pp. 80- 90 ,(2016) , 10.1016/J.NBD.2015.12.009
Andrés Miguez, Gerardo García-Díaz Barriga, Verónica Brito, Marco Straccia, Albert Giralt, Silvia Ginés, Josep M. Canals, Jordi Alberch, Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation Human Molecular Genetics. ,vol. 24, pp. 4958- 4970 ,(2015) , 10.1093/HMG/DDV218
Glenn M Dallérac, Damian M Cummings, Mark C Hirst, Austen J Milnerwood, Kerry PSJ Murphy, None, Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease. Neuromolecular Medicine. ,vol. 18, pp. 146- 153 ,(2016) , 10.1007/S12017-016-8384-Z
Daniel J. Hegeman, Ellie S. Hong, Vivian M. Hernández, C. Savio Chan, The external globus pallidus: progress and perspectives. European Journal of Neuroscience. ,vol. 43, pp. 1239- 1265 ,(2016) , 10.1111/EJN.13196
Peter Langfelder, Jeffrey P Cantle, Doxa Chatzopoulou, Nan Wang, Fuying Gao, Ismael Al-Ramahi, Xiao-Hong Lu, Eliana Marisa Ramos, Karla El-Zein, Yining Zhao, Sandeep Deverasetty, Andreas Tebbe, Christoph Schaab, Daniel J Lavery, David Howland, Seung Kwak, Juan Botas, Jeffrey S Aaronson, Jim Rosinski, Giovanni Coppola, Steve Horvath, X William Yang, Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice Nature Neuroscience. ,vol. 19, pp. 623- 633 ,(2016) , 10.1038/NN.4256
Rachel J. Sizemore, Sonja Seeger-Armbruster, Stephanie M. Hughes, Louise C. Parr-Brownlie, Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology Journal of Neurophysiology. ,vol. 115, pp. 2124- 2146 ,(2016) , 10.1152/JN.01131.2015
Verónica Brito, Silvia Ginés, p75NTR in Huntington's disease: beyond the basal ganglia. Oncotarget. ,vol. 7, pp. 1- 2 ,(2016) , 10.18632/ONCOTARGET.6646
Faye Begeti, Laetitia C Schwab, Sarah L Mason, Roger A Barker, Hippocampal dysfunction defines disease onset in Huntington's disease Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 87, pp. 975- 981 ,(2016) , 10.1136/JNNP-2015-312413
Haiqun Jia, Ying Wang, Charles D. Morris, Vincent Jacques, Joel M. Gottesfeld, James R. Rusche, Elizabeth A. Thomas, The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice PLOS ONE. ,vol. 11, pp. e0152498- ,(2016) , 10.1371/JOURNAL.PONE.0152498